Kimberley J. Holt

Manchester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Prospective study to evaluate the effectiveness of guideline-based therapy for chronic cough and refractory chronic cough: PROCOUGH.

Prospective study to evaluate the effectiveness of guideline-based therapy for chronic cough and refractory chronic cough: PROCOUGH.

Journal: ERJ open research

Published: February 18, 2026

Low-dose morphine and airway sensations in refractory chronic cough: a randomised control trial.

Low-dose morphine and airway sensations in refractory chronic cough: a randomised control trial.

Journal: ERJ open research

Published: January 30, 2026

Reply to: Is the role of eosinophils in refractory chronic cough truly dismissed? Mepolizumab reduced blood and sputum eosinophils, but not eosinophil-derived neurotoxin.

Reply to: Is the role of eosinophils in refractory chronic cough truly dismissed? Mepolizumab reduced blood and sputum eosinophils, but not eosinophil-derived neurotoxin.

Journal: The European respiratory journal

Published: January 19, 2026

Characterizing Cough and Its Response to Therapy in Hypersensitivity Pneumonitis.

Characterizing Cough and Its Response to Therapy in Hypersensitivity Pneumonitis.

Journal: Chest

Published: October 15, 2025

Characterising cough and its response to therapy in hypersensitivity pneumonitis.

Characterising cough and its response to therapy in hypersensitivity pneumonitis.

Journal: Chest

Published: October 15, 2025

Mepolizumab for the treatment of refractory chronic cough in patients with eosinophilic airways disease (MUCOSA): a randomised, double-blind, parallel-group, placebo-controlled trial.

Mepolizumab for the treatment of refractory chronic cough in patients with eosinophilic airways disease (MUCOSA): a randomised, double-blind, parallel-group, placebo-controlled trial.

Journal: The European respiratory journal

Published: July 28, 2025

Protocol for a double-blind crossover randomised controlled trial to investigate inhalation challenge to assess inducible laryngeal obstruction: CH-ILO.

Protocol for a double-blind crossover randomised controlled trial to investigate inhalation challenge to assess inducible laryngeal obstruction: CH-ILO.

Journal: ERJ open research

Published: August 01, 2024

Comparison of different nebulisation systems for capsaicin cough challenge testing.

Comparison of different nebulisation systems for capsaicin cough challenge testing.

Journal: ERJ open research

Published: May 23, 2024

An exploration of clinically meaningful definitions of cough bouts.

An exploration of clinically meaningful definitions of cough bouts.

Journal: ERJ open research

Published: March 28, 2024

How often do healthy people cough?

How often do healthy people cough?

Journal: Respiratory research

Published: September 11, 2023

Novel capsaicin cough endpoints effectively discriminate between healthy controls and patients with refractory chronic cough.

Novel capsaicin cough endpoints effectively discriminate between healthy controls and patients with refractory chronic cough.

Journal: Respiratory medicine

Published: December 01, 2022

A double-blind randomised placebo-controlled trial investigating the effects of lesogaberan on the objective cough frequency and capsaicin-evoked coughs in patients with refractory chronic cough.

A double-blind randomised placebo-controlled trial investigating the effects of lesogaberan on the objective cough frequency and capsaicin-evoked coughs in patients with refractory chronic cough.

Journal: ERJ open research

Published: September 08, 2021

Showing 1-12 of 30

Last Updated: 09/26/2026